HPM
AZN icon

Hoxton Planning & Management’s AstraZeneca AZN Stock Holding History

Hoxton Planning & Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
1,504
+40
+3% +$7.52K 0.07% 184
2026
Q1 		$289K Sell
1,464
-50
-3% -$9.64K 0.09% 167
2025
Q4 		$278K Buy
1,514
+49
+3% +$8.59K 0.08% 169
2025
Q3 		$225K Buy
+1,465
New +$222K 0.07% 194
2024
Q4 		– Sell
-1,331
Closed -$207K – 209
2024
Q3 		$207K Hold
1,331
– – 0.08% 195
2024
Q2 		$208K Buy
+1,331
New +$200K 0.1% 152

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Hoxton Planning & Management's AZN Position: Q2 2026 in Review

Hoxton Planning & Management increased its AstraZeneca (AZN) stake by 2.7% in Q2 2026, buying an estimated $7.52K and bringing the position to 1,504 shares worth $285K. The position accounts for 0.07% of the portfolio, ranked #184.

Hoxton Planning & Management first reported a position in AZN in Q2 2024 and has held it in 6 quarters since. The position peaked at $289K in Q1 2026. 309 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hoxton Planning & Management held 1,504 shares of AstraZeneca worth $285K as of Q2 2026.
  • Hoxton Planning & Management bought 40 AstraZeneca shares in Q2 2026, an estimated $7.52K.
  • AstraZeneca made up 0.07% of Hoxton Planning & Management's portfolio in Q2 2026, its #184 holding.
  • Hoxton Planning & Management first reported a position in AstraZeneca in Q2 2024 and has held it in 6 quarters since.
  • Hoxton Planning & Management's AstraZeneca position peaked at $289K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.